Page last updated: 2024-10-24

chloroquine and Granulomatosis, Orofacial

chloroquine has been researched along with Granulomatosis, Orofacial in 1 studies

Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.

Granulomatosis, Orofacial: A condition characterized by persistent or recurrent labial enlargement, ORAL ULCER, and other orofacial manifestations in the absence of identifiable CROHN DISEASE; or SARCOIDOSIS. Among experts there is disagreement on whether orofacial granulomatosis is a distinct clinical disorder or an initial presentation of Crohn disease.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lalosevic, J1
Gajic-Veljic, M1
Nikolic, M1

Other Studies

1 other study available for chloroquine and Granulomatosis, Orofacial

ArticleYear
Orofacial granulomatosis in a 12-year-old girl successfully treated with intravenous pulse corticosteroid therapy and chloroquine.
    Pediatric dermatology, 2017, Volume: 34, Issue:6

    Topics: Antirheumatic Agents; Child; Chloroquine; Female; Glucocorticoids; Granulomatosis, Orofacial; Humans

2017